RankAlpha logo
Back to Rankings

VOR

Vor BiopharmaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Completed UPSTREAM MG enrollment reduces one execution uncertainty, while the expected first-half 2027 readout offers substantial upside if global efficacy and safety support registration. Vor reported $466.1 million of June cash and investments plus $48.4 million of July ATM proceeds, with projected runway into early 2029.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -2.9.
What can break
Cash-runway guidance depends on development spending and assumptions; additional issuance could dilute shareholders.
Momentum
39
Value
41
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $16.00 · Bull $30.00 · Bear $7.00Analysis 2026-09-27; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-27 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-26

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $39.00
Why
Momentum39 · Δ7d -1.2
Value41 · Δ7d -0.0
Sentiment49 · Δ7d -2.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • • Sentiment remains the lead driver in the composite, 7D delta -2.9.

Contradictions & invalidation

  • • Cash-runway guidance depends on development spending and assumptions; additional issuance could dilute shareholders.
  • • Chinese telitacicept approvals do not establish approval or commercial uptake in Vor’s intended markets outside China.
  • • The global Phase 3 result remains unproven, SjD has no announced readout date, and launching oMG could raise spending.

Catalyst clock

2027-06-30

UPSTREAM MG Phase 3 topline results

Lead driver: Sentiment · See AI snapshot
Momentum
39
8% active weight
Current posture
7d trendSoftening
Δ7d
-1.2
Δ21d
+2.2
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
49
45% active weight
Current posture
7d trendSoftening
Δ7d
-2.9
Δ21d
-5.4
Why this grade

Composite grade D. Momentum 39.0 / Value 40.6 / Sentiment 48.7

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-27. Scenario method

B+
Bull case
0%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
Most likely
B
Base case
1%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$7.00
Analysis reference price unavailable
Analysis 2026-09-27 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$1.08B
Beta
2.03
Shares Out
59.16M
P/E (TTM) · Derived
-0.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.83
Rev YoY
-
EPS YoY
-99.5%
Gross Margin
-
Op Margin
-
Net Debt
-$452.21M
Current Ratio
19.15
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data